Loading...
Efficacy of combined CDK9/BET inhibition in preclinical models of MLL-rearranged acute leukemia
Cyclin-dependent kinase 9 and bromodomain and extraterminal inhibitors are synergistic in MLL-rearranged leukemia. Multiple AML driver genes are downregulated by the combined therapy suggesting broad applicability for this subtype.
Na minha lista:
| Udgivet i: | Blood Adv |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society of Hematology
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6988396/ https://ncbi.nlm.nih.gov/pubmed/31971998 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2019000586 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|